30 min

A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke Treating Blood Cancers

    • Science

Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL















Recorded on September 3, 2019





Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today!

Frederick L. Locke, MD

Vice-Chair

Research Director and Medical Director, Immune Cell Therapy Program

Department of Blood and Marrow Transplant and Cellular Immunotherapy

Co-Leader Immunology Program

Moffitt Cancer Center

Tampa, FL









This podcast episode is supported by Allogene Therapeutics, Inc.

Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL















Recorded on September 3, 2019





Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today!

Frederick L. Locke, MD

Vice-Chair

Research Director and Medical Director, Immune Cell Therapy Program

Department of Blood and Marrow Transplant and Cellular Immunotherapy

Co-Leader Immunology Program

Moffitt Cancer Center

Tampa, FL









This podcast episode is supported by Allogene Therapeutics, Inc.

30 min

Top Podcasts In Science